The Role of Rho Kinase Inhibitors in Corneal Diseases
Drug Design, Development and Therapy · 2024-01 · Volume 18 · 97-108
DOI: 10.2147/dddt.s435522 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-01. Verfasst von Stefan Futterknecht und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Amides, Benzoates, beta-Alanine. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland.
- Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
- Department of Ophthalmology, School of Medicine, University of Basel, Basel, Switzerland.
- Department of Ophthalmology, Queen's Medical Centre, Nottingham University Hospitals, Nottingham, UK.
- Division of Ophthalmology and Visual Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
ORCID-Profile: Stefan Futterknecht, Georgios D Panos
Zitieren
APA
Futterknecht, S., Chatzimichail, E., Gugleta, K., Panos, G. D., & Gatzioufas, Z. (2024). The Role of Rho Kinase Inhibitors in Corneal Diseases. Drug Design, Development and Therapy, Volume 18, 97-108. https://doi.org/10.2147/dddt.s435522
Vancouver
Futterknecht S, Chatzimichail E, Gugleta K, Panos GD, Gatzioufas Z. The Role of Rho Kinase Inhibitors in Corneal Diseases. Drug Design, Development and Therapy. 2024;Volume 18:97-108. doi:10.2147/dddt.s435522
BibTeX
@article{Futterknecht2024,
author = {Futterknecht, Stefan and Chatzimichail, Eleftherios and Gugleta, Konstantin and Panos, Georgios D and Gatzioufas, Zisis},
title = {The Role of Rho Kinase Inhibitors in Corneal Diseases},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {97--108},
doi = {10.2147/dddt.s435522}
}
EUVIMED